Dr Elizabeth Batty
Contact information
Research groups
Elizabeth Batty
Head of Molecular Microbiology
Microbiology
I research the genomics of microbial pathogens with researchers from across the MORU network. My current projects include the genomics of Orientia tsutsugamushi, the causative agent of scrub typhus, and tracking the transmission of E. coli and K. pneumoniae in hospitals and the community in Cambodia. I am also interested in new sequencing technologies and work with colleagues in Cambodia and Laos to perform sequencing in those countries, and run workshops to train local researchers in computing and bioinformatics.
Key publications
-
Detection of maternal transmission of resistant Gram-negative bacteria in a Cambodian hospital setting
Chomkatekaew C. et al, (2023), Frontiers in Microbiology, 14
-
AmpC β-lactamases detected in Southeast Asian Escherichia coli and Klebsiella pneumoniae
Roberts T. et al, (2024), JAC-Antimicrobial Resistance, 6
-
Targeted capture and sequencing of Orientia tsutsugamushi genomes from chiggers and humans.
Elliott I. et al, (2021), Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 91
-
Evolutionary history of the global emergence of the Escherichia coli epidemic clone ST131
Stoesser N. et al, (2015)
-
Oxford Nanopore MinION sequencing enables rapid whole-genome assembly ofRickettsia typhiin a resource-limited setting
Elliott I. et al, (2018)
Recent publications
-
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV).
Jittamala P. et al, (2025), EClinicalMedicine, 80
-
AmpC β-lactamases detected in Southeast Asian Escherichia coli and Klebsiella pneumoniae
Roberts T. et al, (2024), JAC-Antimicrobial Resistance, 6
-
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
Schilling WHK. et al, (2024), PLoS medicine, 21
-
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
Wongnak P. et al, (2024), The Lancet Infectious Diseases, 24, 953 - 963
-
Addressing pandemic-wide systematic errors in the SARS-CoV-2 phylogeny
Hunt M. et al, (2024)